drugset / Trial / NCT03104283
Apatinib for the Elderly Advanced Gastric Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of our study is to assess the efficacy and safety of apatinib in elderly advanced gastric cancer patients, and to find the relationship between the expression of VEGFR-2 and efficacy of apatinib treatment.
Timeline
- Start
- 2017-06-05
- Primary completion
- 2019-12-01
- Completion
- 2020-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 250 mg | Oral |
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |